BACKGROUND: We conducted a 3-year, double-blind, randomized, placebo-controlled study to determine whether the positive effects of hormone/estrogen replacement therapy (H/ERT) on postcranial bone density are accompanied by similar positive effects on oral bone mass. METHODS: A total of 135 postmenopausal women (aged 41-70 years) with no evidence of moderate or severe periodontal disease were randomized to receive daily oral conjugated estrogen (Premarin; 0.625 mg) alone or in combination with medroxyprogesterone acetate (Prempro; 0.625 and 2.5 mg, respectively) or placebo. All subjects received calcium carbonate (1000 mg/d) and cholecalciferol (400 [corrected] IU/d) supplements. The primary efficacy end points were the changes in alveolar crest height and alveolar bone density. Alveolar crest height was measured on bite-wing radiographs, and changes in alveolar bone mass were assessed by means of digital-subtraction radiography. Postcranial bone density was measured in the lumbar spine and left proximal femur by means of dual-energy x-ray absorptiometry. RESULTS:Hormone/estrogen replacement therapy significantly increased alveolar bone mass compared with placebo (+1.84% vs +0.95% [P =.04]), and tended to improve alveolar crest height (+4.83% vs +3.46% [P =.34]). Bone mineral density of the proximal femur significantly increased in the H/ERT compared with the placebo group (total proximal femur, +3.59% vs +0.22% [P =.001]; neck, +2.05% vs -0.34% [P =.02]; trochanter, +3.49% vs +0.08% [P<.001]), but not the lumbar spine (+1.01% vs +0.17% [P =.39]). Changes in alveolar bone mass correlated with bone density changes in the total femur (r = 0.28 [P =.02]) and femoral trochanter (r = 0.25 [P =.04]) in the H/ERT but not in the placebo group. CONCLUSIONS:Postcranial and oral bone mass were increased in postmenopausal women receiving H/ERT. Improvement in oral bone health constitutes an additional benefit of H/ERT.
RCT Entities:
BACKGROUND: We conducted a 3-year, double-blind, randomized, placebo-controlled study to determine whether the positive effects of hormone/estrogen replacement therapy (H/ERT) on postcranial bone density are accompanied by similar positive effects on oral bone mass. METHODS: A total of 135 postmenopausal women (aged 41-70 years) with no evidence of moderate or severe periodontal disease were randomized to receive daily oral conjugated estrogen (Premarin; 0.625 mg) alone or in combination with medroxyprogesterone acetate (Prempro; 0.625 and 2.5 mg, respectively) or placebo. All subjects received calcium carbonate (1000 mg/d) and cholecalciferol (400 [corrected] IU/d) supplements. The primary efficacy end points were the changes in alveolar crest height and alveolar bone density. Alveolar crest height was measured on bite-wing radiographs, and changes in alveolar bone mass were assessed by means of digital-subtraction radiography. Postcranial bone density was measured in the lumbar spine and left proximal femur by means of dual-energy x-ray absorptiometry. RESULTS: Hormone/estrogen replacement therapy significantly increased alveolar bone mass compared with placebo (+1.84% vs +0.95% [P =.04]), and tended to improve alveolar crest height (+4.83% vs +3.46% [P =.34]). Bone mineral density of the proximal femur significantly increased in the H/ERT compared with the placebo group (total proximal femur, +3.59% vs +0.22% [P =.001]; neck, +2.05% vs -0.34% [P =.02]; trochanter, +3.49% vs +0.08% [P<.001]), but not the lumbar spine (+1.01% vs +0.17% [P =.39]). Changes in alveolar bone mass correlated with bone density changes in the total femur (r = 0.28 [P =.02]) and femoral trochanter (r = 0.25 [P =.04]) in the H/ERT but not in the placebo group. CONCLUSIONS: Postcranial and oral bone mass were increased in postmenopausal women receiving H/ERT. Improvement in oral bone health constitutes an additional benefit of H/ERT.
Authors: Ricardo C Alves; Sérgio A Félix; Alberto Rodriguez-Archilla; Pedro Oliveira; José Brito; José Martins Dos Santos Journal: Int J Clin Exp Med Date: 2015-07-15
Authors: Youjin Wang; Michael J LaMonte; Kathleen M Hovey; Xiaodan Mai; Mine Tezal; Amy E Millen; Heather M Ochs-Balcom; Robert J Genco; Vanessa M Barnabei; Jean Wactawski-Wende Journal: J Periodontol Date: 2015-01-16 Impact factor: 6.993
Authors: M Nathalia Garcia; Charles F Hildebolt; D Douglas Miley; Debra A Dixon; Rex A Couture; Catherine L Anderson Spearie; Eric M Langenwalter; William D Shannon; Elena Deych; Cheryl Mueller; Roberto Civitelli Journal: J Periodontol Date: 2010-09-01 Impact factor: 6.993
Authors: Jeffrey B Payne; Julie A Stoner; Pirkka V Nummikoski; Richard A Reinhardt; Arthur D Goren; Mark S Wolff; Hsi-Ming Lee; James C Lynch; Robert Valente; Lorne M Golub Journal: J Clin Periodontol Date: 2007-09 Impact factor: 8.728
Authors: Charles F Hildebolt; Rex Couture; Nathalia M Garcia; Debra Dixon; D Doug Miley; William Shannon; Cheryl Mueller; Eric Langenwalter; Cathy Anderson Spearie; R Civitelli Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Date: 2009-09
Authors: J S Passos; M I P Vianna; I S Gomes-Filho; S S Cruz; M L Barreto; L Adan; C K Rösing; E M M Cerqueira; S C Trindade; J M F Coelho Journal: Osteoporos Int Date: 2012-09-22 Impact factor: 4.507